Consumer Health

Ecuador is expected to register only a slight increase in current value sales in 2023. Ecuador is grappling with rising crime rates and political instability, with runoff elections scheduled in October. This is all leading to economic uncertainty and…

Sales growth of consumer health in El Salvador in 2023 varied across categories. While OTC performed well, growing at above inflation, preventive health categories such as vitamins, dietary supplements and weight management recorded significant…

Consumer health has seen demand dampened by consumers being confronted with very high inflation. The rate of 9.2% in 2022 was the highest experienced in decades. As a result, more consumers have been forced to prioritise household spending on…

Consumer health in Honduras experienced a year of growth in value terms in 2023 that was in line with the country's inflation. Categories such as analgesics, cough, cold and allergy (hay fever) remedies, dermatologicals, and sports nutrition…

Emerging from the pandemic, Latin America moved into a period of high inflation, with both factors hitting consumer health sales in 2022. The large Brazilian market was facing new health challenges in the form of arboviruses, especially dengue, in…

In 2023, after three years of placing health at the forefront due to the pandemic, Mexicans have finally found some respite and are shifting their focus away from health concerns. While the public healthcare system grapples with supply shortages,…

Consumer health sales grew moderately in 2023 as consumers prioritised their spending on essential goods over preventive health. As a result, vitamins and dietary supplements and weight management and wellbeing were the most affected. However, sports…

Consumer health declined in volume sales while retail value sales grew below inflation in 2023. This was mainly due to significant falls in the vitamins and dietary supplements and weight management and wellbeing categories while sports nutrition and…

Consumer health shows variable recovery in 2023, with an ongoing return to the normalisation of sales patterns following the atypical period of the pandemic. Challenges, however, continue, such as the departure of President Castillo's government, in…

The picture is fairly positive in 2023, with constant value sales expected to rise slightly and inflationary pressure easing. However, rising prices are still an issue and the overall economy is expected to register a slowdown in growth.

Retail sales of cough, cold and allergy (hay fever) remedies saw another year of healthy growth in constant value terms in 2023. With the resumption of pre-pandemic lifestyles, including a return to work, school and social activities, consumers…

Seasonal flus have returned, as people mix together once again , post pandemic, and cough, cold and allergy (hay fever remedies) are expected to register moderate current value growth, though constant value growth will be minimal, as rising costs hit…

In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…

Cough, cold, and allergy (hay fever) remedies in Chile is experiencing remarkable growth for the second consecutive year in 2023, both in terms of volume and value. This upward trend can be attributed primarily to the return to normalcy following the…

In 2022, demand for cold, cough and allergy (have fever) remedies soared, as a result of the atypical increase in flu cases, as social distancing, handwashing protocols, and the use of face masks were totally lifted in 2022, facilitating the spread…

At the end of 2022, there was an increase in the need to treat cold and flu symptoms. This was driven by the return of socialising following periods of social distancing, increased hand washing and the wearing of face masks throughout most of 2020…

Cough, cold and allergy (hay fever) remedies are among the most popular consumer health items in the Dominican Republic and are experiencing further growth in 2023 despite higher unit prices resulting largely from persistent inflationary pressures…

Cough, cold and allergy (hay fever) remedies are expected to register a decline in value sales. Value sales are now at more normal levels, as concerns about the COVID-19 virus have abated. In addition, Ecuador is grappling with rising crime rates and…

Cough, cold and allergy (hay fever) remedies are widely consumed consumer health items in the Guatemalan market. These products have established broad distribution throughout the country, with products available throughout the modern and traditional…

In early 2023, a sixth wave of COVID-19 coincided with an upsurge in cases of the common cold and influenza, creating a "tripledemic" felt across Mexico, the US, and Central American countries, with Mexico experiencing a milder impact. This scenario…